Dermal & Cellular Research Bundle x 9 Vials (GHK-Cu 50mg / KPV 10mg / Glutathione 1500mg)

In fibroblast and skin-equivalent cultures, the three processes this set covers rarely move on their own. Inflammatory cytokines such as IL-1 and TNF-alpha push fibroblasts to release matrix metalloproteinases that break collagen down, oxidative stress drives the same enzymes and feeds inflammatory signalling in turn, and the matrix sends cues back to the cells embedded in it. The bundle splits that loop into three handles. GHK-Cu is the tool for questions about matrix synthesis and turnover, KPV for asking how much of a change depends on inflammatory signalling, and glutathione for setting or probing the redox state of the culture. Used side by side, they help a study separate cause from consequence: if collagen output falls under a cytokine challenge, is it rescued by restoring matrix signals, by quietening the inflammatory input, or only by correcting redox balance?

Glutathione is a strong reducing agent and a capable copper ligand. In solution its cysteine thiol can reduce copper(II) to copper(I) and bind the reduced metal, forming copper–glutathione complexes while part of the glutathione is oxidised to GSSG. GHK holds its copper very tightly, but whether a large excess of glutathione can strip or reduce some of it under your particular buffer, pH and timing is something to measure rather than assume. Copper cycling with thiols can also generate reactive oxygen species, which would muddy any redox readout. We know of no published work characterising this exact pairing, so three habits are worth adopting: dissolve and store the two separately, add them to cultures as separate additions rather than one pre-mixed stock, and run a cell-free GHK-Cu-plus-glutathione control checked by UV-visible absorbance or LC-MS before interpreting any biology.

A clean starting design uses an untreated control, a challenge-only group (an inflammatory cytokine or a measured UV exposure), each compound alone under challenge, the three pairs, and all three together. Readouts should cover every pathway in every arm: pro-collagen I secretion or hydroxyproline for matrix, MMP-1 and IL-6 or IL-8 for inflammatory tone, and intracellular GSH:GSSG or a ROS-sensitive dye for redox state. An arm that only reports collagen cannot show whether a change travelled through inflammation or oxidation, which is the whole reason for grouping these compounds. Three vials of each suit a pilot, main run and reserve pattern: the first set for single-agent concentration finding, the second for the full factorial experiment, and the third left sealed so a repeat uses material from the same supply.

Label weights hide a large molar spread. A 50mg GHK-Cu vial (about 401.9 g/mol as the copper complex) holds roughly 124 micromoles, a 10mg KPV vial (about 342.4 g/mol) close to 29 micromoles, and a 1500mg glutathione vial (about 307.3 g/mol) almost 4.9 millimoles: around 39 times the GHK-Cu and more than 160 times the KPV, molecule for molecule. That reflects use rather than imbalance. Cells keep glutathione in the millimolar range, so experiments that add it to media or buffers work at that scale, whereas the two signalling peptides are tested at far lower concentrations. A vial’s stated mass can include counter-ions and residual water, so check net content on each Certificate of Analysis before calculating molarity.